Pediatric pharmacotherapy: optimising children’s health

About the Article Collection

This Article Collection will examine the development of pediatric pharmacotherapy from the perspective of drug development, diagnostics, its interaction with science, its interconnection with regulatory issues, conflicts of interest of the institutions involved, as well as the latest advancements and challenges within the field. Our esteemed contributors, renowned experts in the field and industry, offer insights into diverse and insightful topics such as pediatric drug development (PDD), breakthroughs in pediatric oncology, vaccine development, cystic fibrosis, neurodevelopmental diseases, and more.

From discussing pediatric legislation to improving treatment outcomes, this Article Collection serves as a comprehensive guide for healthcare professionals, researchers, and policymakers striving to ensure the best possible pharmacotherapy for our youngest patients. Join us as we navigate the complexities of pediatric pharmacology and work towards enhancing the health and well-being of children and adolescents worldwide.

This Article Collection welcomes authors to submit Reviews, Original Research, Drug Evaluations, and short Editorial articles.

The benefit of publishing as part of an Article Collection is that they often become a key resource, driving a research community forward. This has a synergistic effect on every article in the Collection. The articles often receive more views and higher citation numbers as the Collections receive increased promotion via social media and our marketing team. 

If you are interested in contributing, or would like to learn more, then please reach out to the Commissioning Editor, Rayya Hajar, who will be happy to assist.